Embed Size (px)
Citation preview
U.S. Emerging Prostate Cancer Therapeutics Markets
Development of New Products with Fewer Adverse Patient Reactions Drives Market
"Promoting a product based on superior anti-tumor activity, with less toxicity and without compromising the quality of life of patients, is going to be key to
the success of any newly approved product."
Pharmaceuticals Analyst Team
Frost & Sullivan
• Detailed insights into recent developments and trends
• Drivers, restraints, challenges, and strategic recommendations
• Analytical insights into current topics and emerging applications in the prostate cancer therapeutics market
• Market-sizing and competitive analysis
• Market forecasts and opportunity analyses
• Quarterly assessments
• End-user analysis
Key Features
• Coverage: The United States
• Proven methodology using extensive primary and secondary data as well as research
• Focused information and strategies that cover business and technology issues
• Credible data and analyses that highlight industry dynamics
• Precise strategies to help you create winning business plans
What We Offer
Current Market Participants• Find out where you stand in comparison with the competitors• Assess current and future drivers as well as restraints• Determine and exploit new market share opportunities
New Entrants • Analyze the associated challenges• Calculate timescales for strategy implementation• Position yourself to capitalize on the unmet needs of the market
Investment Community• Analyze long-term strategies of companies • Determine which participants will outperform the competition• Assess the attractiveness of investing in the market
Who Will Benefit?
Aeterna Laboratories, Inc.Alfacell Corp.Amgen, Inc.Aphton Corp.AstraZeneca Pharmaceuticals LPAtrix Laboratories, Inc.Aventis Pharmaceuticals, Inc.Bone Care InternationalBristol-Myers Squibb, Inc.Calydon, Inc.Celgene Corp.Cell Genesys, Inc.Cell Pathways, Inc.Cell Therapeutics, Inc.Cephalon, Inc.Cytran, Inc.Dendreon Corp.Eli Lilly and Co.EntreMed, Inc.Epic Therapeutics, Inc.
Key Market Participants
Genaera Corp.Genentech, Inc.Genta, Inc.ILEX Oncology, Inc.Medarex, Inc.MGI Pharma, Inc.Myriad Genetics, IncNorthwest Biotherapeutics, Inc.Novartis Pharmaceuticals Corp.Pharmacia Corp.Praecis PharmaceuticalsProtarga, Inc.Seattle Genetics, Inc.Shire Pharmaceutical Group PlcTAP Pharmaceutical Products, Inc.Therion Biologics Corp.Titan Pharmaceuticals, Inc.Vical, Inc.YM BioSciences, Inc.
• Call toll free 877 GO FROST
(877.463.7876)
• Fax toll free 888.690.3329
• E-mail [email protected]
• Visit www.frost.com
For More Information
